129 related articles for article (PubMed ID: 8043502)
1. Immunocytochemical versus biochemical receptor determination in normal and tumorous tissues of the female reproductive tract and the breast.
Zeimet AG; Müller-Holzner E; Marth C; Daxenbichler G
J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):365-72. PubMed ID: 8043502
[TBL] [Abstract][Full Text] [Related]
2. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
4. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
[TBL] [Abstract][Full Text] [Related]
6. Comparison of monoclonal immunocytochemical and immunoenzymatic methods for steroid receptor evaluation in breast cancer.
De Negri F; Campani D; Sarnelli R; Martini L; Gigliotti A; Bonacci R; Fabbri R; Squartini F; Pinchera A; Giani C
Am J Clin Pathol; 1991 Jul; 96(1):53-8. PubMed ID: 2069136
[TBL] [Abstract][Full Text] [Related]
7. Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis.
Kommoss F; Pfisterer J; Idris T; Giese E; Sauerbrei W; Schäfer W; Thome M; Pfleiderer A
Anal Quant Cytol Histol; 1994 Jun; 16(3):203-10. PubMed ID: 7916848
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical staining of progesterone receptor in paraffin sections of human breast cancers.
Perrot-Applanat M; Groyer-Picard MT; Vu Hai MT; Pallud C; Spyratos F; Milgrom E
Am J Pathol; 1989 Sep; 135(3):457-68. PubMed ID: 2675623
[TBL] [Abstract][Full Text] [Related]
9. Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?
Kiang DT; Kollander R
J Clin Oncol; 1987 Apr; 5(4):662-6. PubMed ID: 2435857
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical analysis of progesterone receptors in breast cancer.
Masood S; Dee S; Goldstein JD
Am J Clin Pathol; 1991 Jul; 96(1):59-63. PubMed ID: 1712544
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle.
Hild-Petito S; Stouffer RL; Brenner RM
Endocrinology; 1988 Dec; 123(6):2896-905. PubMed ID: 3197647
[TBL] [Abstract][Full Text] [Related]
12. Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness.
Navarro D; Cabrera JJ; León L; Chirino R; Fernández L; López A; Rivero JF; Fernández P; Falcón O; Jiménez P
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):589-96. PubMed ID: 1562530
[TBL] [Abstract][Full Text] [Related]
13. Paraffin section immunocytochemistry and cytosol-based ligand-binding assays for ER and PR detection in breast cancer: the time has come for more objectivity.
Goussard J
Cancer Lett; 1998 Oct; 132(1-2):61-6. PubMed ID: 10397454
[TBL] [Abstract][Full Text] [Related]
14. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
15. The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer.
Chen S; Dai X; Gao Y; Shen F; Ding J; Chen Q
Sci Rep; 2017 Dec; 7(1):16922. PubMed ID: 29208958
[TBL] [Abstract][Full Text] [Related]
16. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast.
Battersby S; Robertson BJ; Anderson TJ; King RJ; McPherson K
Br J Cancer; 1992 Apr; 65(4):601-7. PubMed ID: 1562470
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
Maleeva A; Milkov V
Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and histochemical analysis of steroid hormone binding sites in human primary breast cancer.
Janssens JP; Pylyser K; Bekaert J; Roelens J; Stuyck J; Dekeyser LJ; Lauweryns JM; De Loecker W
Cancer; 1985 Jun; 55(11):2600-11. PubMed ID: 2986819
[TBL] [Abstract][Full Text] [Related]
19. Potential value of estrogen receptor immunocytochemical assay in formalin-fixed breast tumors.
Masood S; Lu L; Rodenroth N
Mod Pathol; 1990 Nov; 3(6):724-8. PubMed ID: 1702213
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
Oyaizu T; Arita S; Hatano T; Tsubura A
J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
